(Q34109021)

31 July 2017

1 reference

title

Use of biologics in the treatment of childhood rheumatic diseases (English)

1 reference

31 July 2017

Arkachaisri T

1

1 reference

PubMed ID

11123079

31 July 2017

Lehman TJ

series ordinal

2

1 reference

31 July 2017

1 August 2000

1 reference

Current Rheumatology Reports

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

4

1 reference

31 July 2017

330-336

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-000-0071-1

31 July 2017

0 references

cites work

Inflammatory cytokine responses in juvenile chronic arthritis

1 reference

12 December 2020

Long-term toxicity of immune suppression in juvenile rheumatic diseases

1 reference

12 December 2020

Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis

1 reference

12 December 2020

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

1 reference

12 December 2020

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

1 reference

12 December 2020

Use of recombinant interferon gamma in pediatric patients with advanced juvenile chronic arthritis

1 reference

12 December 2020

A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis

1 reference

12 December 2020

A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis

1 reference

12 December 2020

Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis

1 reference

12 December 2020

Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis

1 reference

12 December 2020

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

1 reference

12 December 2020

Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

12 December 2020

Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

Biologic agents for treating rheumatoid arthritis. Concepts and progress

1 reference

12 December 2020

Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters

1 reference

12 December 2020

Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis

1 reference

12 December 2020

Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Soluble adhesion molecules in juvenile rheumatoid arthritis

1 reference

12 December 2020

Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis

1 reference

12 December 2020

Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody

1 reference

12 December 2020

Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-alpha 4 antibody in adjuvant arthritis

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis

1 reference

12 December 2020

Interleukin 6 levels in synovial fluids of patients with different arthritides: correlation with local IgM rheumatoid factor and systemic acute phase protein production

1 reference

12 December 2020

Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial

1 reference

12 December 2020

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

12 December 2020

Soluble intercellular adhesion molecule-1 in paediatric connective tissue diseases

1 reference

12 December 2020

Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease.

1 reference

12 December 2020

Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis

1 reference

12 December 2020

Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody

1 reference

12 December 2020

Interleukin-1 receptor antagonist

1 reference

12 December 2020

Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis

1 reference

12 December 2020

Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis

1 reference

12 December 2020

Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules

1 reference

12 December 2020

Prognosis in children with rheumatic diseases: justification for consideration of new therapies.

1 reference

12 December 2020

Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2).

1 reference

12 December 2020

IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy

1 reference

12 December 2020

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

1 reference

12 December 2020

Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.

1 reference

12 December 2020

Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?

1 reference

12 December 2020

Absence of association between interleukin 1 alpha and oligoarticular juvenile chronic arthritis in UK patients

1 reference

12 December 2020

Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis

1 reference

12 December 2020

10.1007/S11926-000-0071-1

Identifiers

DOI

1 reference

PubMed ID

11123079

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11123079